Global Acute Myeloid Leukemia Diagnostics Market to 2032
Overview
The Global Acute Myeloid Leukemia Diagnostics Market is expected to reach a 7.26 USD Billion by 2032 and is projected to grow at a CAGR of 16.46% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3.09
Forecast, 2032 (USD Billion)
7.26
CAGR, 2024 - 2032
16.46%
Report Coverage
Global
Global Acute Myeloid Leukemia Diagnostics Market 2018-2032 USD Billion
Global Acute Myeloid Leukemia Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3.09 USD Billion
- Projected Market Size (2032): 7.26 USD Billion
- CAGR (2025-2032): 16.46%
Key Findings of Global Acute Myeloid Leukemia Diagnostics Market
- The Global Acute Myeloid Leukemia Diagnostics Market was valued at 3.09 USD Billion in 2024.
- The Global Acute Myeloid Leukemia Diagnostics Market is likely to grow at a CAGR of 16.46% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment 65 and Above in Age Group Segment accounted for the largest share of the market with a revenue of 2.39 USD Billion
- The fastest growing segment Myeloblastic (M0) in Cancer Segment grew Fastest with a CAGR of 23.02% during the forecast period from 2024 to 2032.
Global Acute Myeloid Leukemia Diagnostics Market Scope
Global Acute Myeloid Leukemia Diagnostics Market Segmentation & Scope
Product
- Consumables & Accessories
- Instruments
Test
- Others
- Immunophenotyping
- Biomarker Test
- Genetic Tests
- Bone Marrow Tests
- Imaging Test
- Blood Test
Age Group
- 21-29
- Below 21
- 30-65
- 65 and Above
Gender
- Female
- Male
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Cancer
- Megakaryocytic (M7)
- Erythroleukemia (M6)
- Monocytic (M5)
- Myelomonocytic (M4)
- Promyelocytic (M3)
- Myeloblastic (M2)
- Myeloblastic (M1)
- Myeloblastic (M0)
Global Acute Myeloid Leukemia Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3.09 USD Billion |
| Market Value in 2032 | 7.26 USD Billion |
| CAGR (2025-2032) | 16.46% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Test,Age Group,Gender,End User,Distribution Channel,Cancer |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 3.09 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 893.57 USD Million in 2024.
Segments and Scope
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By Product
- Instruments is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 2.13 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 17.40 % in forecast period 2025-2032.
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By Test
- Blood Test is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 961.99 USD Billion in the year 2024.
- Blood Test is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 21.02 % in forecast period 2025-2032.
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By Age Group
- 65 and Above is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 2.39 USD Billion in the year 2024.
- 65 and Above is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 17.25 % in forecast period 2025-2032.
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By Gender
- Male is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 1.82 USD Billion in the year 2024.
- Male is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 18.36 % in forecast period 2025-2032.
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 1.07 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 21.08 % in forecast period 2025-2032.
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 2.11 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 18.27 % in forecast period 2025-2032.
-
Global Acute Myeloid Leukemia Diagnostics Market to 2032, By Cancer
- Myeloblastic (M0) is the largest segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 904.05 USD Billion in the year 2024.
- Myeloblastic (M0) is the Fastest growing segment in Global Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 23.02 % in forecast period 2025-2032.
Global Acute Myeloid Leukemia Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| Sysmex Corporation | |||
| QIAGEN | |||
| BIOMÉRIEUX | |||
| CANON MEDICAL SYSTEMS CORPORATION | |||
Global Acute Myeloid Leukemia Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Acute Myeloid Leukemia Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Product,Test,Age Group,Gender,End User,Distribution Channel,Cancer.
Global Acute Myeloid Leukemia Diagnostics Market was valued at USD 3.09(Revenue in USD Billion) in 2021.
Global Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 16.46% during the forecast period of 2024 to 2032.
The 65 and Above segment is expected to dominate the Global Acute Myeloid Leukemia Diagnostics Market, holding a largest market share of 2.39 USD Billion in 2024
Global Acute Myeloid Leukemia Diagnostics Market Scope
Global Acute Myeloid Leukemia Diagnostics Market Segmentation & Scope
Product
- Consumables & Accessories
- Instruments
Test
- Others
- Immunophenotyping
- Biomarker Test
- Genetic Tests
- Bone Marrow Tests
- Imaging Test
- Blood Test
Age Group
- 21-29
- Below 21
- 30-65
- 65 and Above
Gender
- Female
- Male
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Cancer
- Megakaryocytic (M7)
- Erythroleukemia (M6)
- Monocytic (M5)
- Myelomonocytic (M4)
- Promyelocytic (M3)
- Myeloblastic (M2)
- Myeloblastic (M1)
- Myeloblastic (M0)
Frequently Asked Questions
The Global Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Product,Test,Age Group,Gender,End User,Distribution Channel,Cancer.
Global Acute Myeloid Leukemia Diagnostics Market was valued at USD 3.09(Revenue in USD Billion) in 2021.
Global Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 16.46% during the forecast period of 2024 to 2032.
The estimated market value of the Global Acute Myeloid Leukemia Diagnostics Market for final year is USD 7.26 (USD Billion).
Global Acute Myeloid Leukemia Diagnostics Market Company Profiling
Frequently Asked Questions
The Global Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Product,Test,Age Group,Gender,End User,Distribution Channel,Cancer.
Global Acute Myeloid Leukemia Diagnostics Market was valued at USD 3.09(Revenue in USD Billion) in 2021.
Global Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 16.46% during the forecast period of 2024 to 2032.
The estimated market value of the Global Acute Myeloid Leukemia Diagnostics Market for final year is USD 7.26 (USD Billion).
CHOOSE LICENCE TYPE
- 7000.00
- 4800.00
- 3200.00
- 8000.00
- 15000.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.